In India, Bayer confronts a shortage of the contraceptive pill Yasmin

Bayer, a German pharmaceutical company, stated that it was experiencing supply issues with its popular oral contraceptive pill Yasmin in India and that supply would recommence in the "next few days".

Since March, approximately forty Indian pharmacies and drug distributors have...

CELLTRION WILL SUPPLY ITS COVID-19 TREATMENT WITHOUT PROFIT MARGIN IN S. KOREA

Highlights –

• Celltrion will supply its COVID-19 treatment without profit margin in S. Korea.
• Celltrion’s CT-P59 began to be supplied to local medical institutions on Wednesday.
• The company has also planned to supply the treatmen...

CELLTRION’S COVID-19 ANTIBODY TREATMENT CONFIRMED TO NEUTRALIZE VIRUS VARIANT

Highlights –

• Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
• The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
• The company has also t...

JAPAN’S KOBAYASHI KAKO CO. RECEIVES AN ORDER TO SUSPEND BUSINESS FOR 116 DAYS

Highlights –

• Japan’s Kobayashi Kako Co. receives an order to suspend business for 116 days.
• The company was guilty of making fictitious production records on nearly 80 percent of its products.
• The company last year had recalled ...

TAKEDA AIMS TO GO PUBLIC IN THE NEXT 5 TO 10 YEARS AFTER BLACKSTONE’S ACQUISITION

Highlights –

• Takeda Pharmaceutical aims to go public in the next 5 to 10 years after Blackstone’s acquisition.
• The unit needs to expand its business overseas in Chinese-speaking markets.
• Takeda plans to sell its drug unit to Bl...

TAKEDA PHARMACEUTICAL CO.RAISED ITS NET PROFIT OUTLOOK FOR THIS YEAR

Highlights –

• Takeda pharmaceutical co. raised its net profit outlook for this year.
• The drug-making company revised its bottom-line outlook to $880 million.
• It also reported an operating profit outlook to $374 million.
• Tak...

LONDON – LISTED SHARES ROSE ON WEDNESDAY

Highlights –

• London-listed shares rose on Wednesday.
• Pharmaceutical companies saw the most gains.
• The blue-chip FTSE 100 .FTSE was up 1.0%.
• Online fashion retailer ASOS (ASOS.L) shares jumped by 2.8%.

On ...

WALL STREET INVESTORS ARE LIKELY TO SHIFT TO LARGE PHARMACEUTICAL COMPANIES

Highlights –

• Wall Street investors are likely to shift to large pharmaceutical companies.
• Investors are moving away from their investment from small biotech firms.
• Big pharma companies are racing over production of COVID-19 vaccines.<...

POP1 Drug Discovery Program Advanced by Propanc Biopharma

Propanc Biopharma, Inc., a biopharmaceutical company creating new cancer therapies for patients with recurrent and metastatic cancer, today reported that the POP1 study and drug discovery program has made great progress in the creation of synthetic variants of both proenzymes, trypsinogen, and ch...

Cipla drops 5 percent as a result of fears against Goa unit

The Indian multinational biotechnology and pharmaceutical company-Cipla has dropped to 5% in Friday’s session. The dive is attributed to extensive changes by Capital market company-Equirius, which said the unit will have to meet the changes as per the USFDA guidelines. 
News sou...